While our findings in AML do concur with these findings, we observed significant down-regulation of the CLOCK gene in patients newly diagnosed with either ALL (Figure 2C) or CML (Figure 3A). This evidence concerns the gene CLOCK and chronic myelogenous leukemia, BCR-ABL1 positive.